Cite

HARVARD Citation

    Galluzzo, M. et al. (2022). Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study. Expert opinion on biological therapy. pp. 547-554. [Online]. 
  
Back to record